Abstract:Iron overload plays a key role in brain injury after intracerebral hemorrhage (ICH). We explored the roles of ferric iron chelator—deferiprone (DFP)—and ferrous iron chelator—clioquinol (CQ)—in ICH rats through the outcomes, iron deposits, reactive oxygen species (ROS), brain water content, and related iron transporters. One hundred eight Sprague-Dawley rats received intra-striatal infusions of 0.5 U of type IV collagenase to establish ICH models. The rats were randomly assigned to the sham, vehicle, DFP, and CQ groups. We evaluated the outcomes, iron levels, brain water content, and ROS; meanwhile, immunohistochemistry and real-time quantitative polymerase chain reaction (RT-qPCR) were utilized to determine ferritin, transferrin, transferrin receptor, divalent metal transport 1 (DMT1), and ferroportin at 48 and 72 h, 7 and 14 days after surgery. Our results showed ICH induced iron overload, brain edema, ROS formation, and neurological deficits. Both iron chelators decreased iron levels; CQ improved the neurological outcome, attenuated brain edema, and ROS production. DFP reduced iron contents but not brain water content and ROS generation. DFP failed to improve the outcome. ICH initiated endogenous iron chelators and transporters, both exogenous iron chelators enhanced expression of transferrin and transferrin receptor. CQ enhanced expression of ferroportin but not DMT1, while DFP enhanced expression of DMT1 but not ferroportin. Ferrous iron contributed to brain injury, and binding ferrous iron can modestly improve outcome after ICH in rats. The exogenous ferrous iron chelator possibly functioned via endogenous ferrous iron transporters on ICH. Therefore, ferrous iron may be a promising target for ICH in future.

The Damage Mechanisms of Iron Ion in Intracerebral Hemorrhage and the Neuroprotective Effects of Iron Chelator

The effect of iron on oxidative injury after cerebral hemorrhage

Activation of C-Jun-n-terminal Kinase in a Rat Model of Intracerebral Hemorrhage: the Role of Iron.

Deferoxamine Reduces CSF Free Iron Levels Following Intracerebral Hemorrhage

Iron toxicity in intracerebral hemorrhage: Physiopathological and therapeutic implications

Iron Accumulation And Dna Damage In A Pig Model Of Intracerebral Hemorrhage

Iron and Intracerebral Hemorrhage: From Mechanism to Translation

Iron Enhances The Neurotoxicity Of Amyloid Beta

Autophagy after Experimental Intracerebral Hemorrhage

Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage

The relationship between hematoma iron content and perihematoma edema: an MRI study.

Iron As A Therapeutic Target In Intracerebral Hemorrhage: Preclinical Testing Of Deferoxamine

Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage

Intracerebral Hemorrhage in the Iron-Deficient Rat

Neuroprotection of brain-permeable iron chelator VK-28 against intracerebral hemorrhage in mice

Iron and Iron-Handling Proteins in the Brain After Intracerebral Hemorrhage

Iron Enhances the Neurotoxicity of Amyloid β

Delayed Neuronal Degeneration after Intracerebral Hemorrhage:The Role of Iron

Effect Comparison of Both Iron Chelators on Outcomes, Iron Deposit, and Iron Transporters After Intracerebral Hemorrhage in Rats

Role of mass effect on neuronal iron deposition after intracerebral hemorrhage